Multiple States Prioritizing COVID Care Based On Race, Thanks To The FDA

Multiple States Prioritizing COVID Care Based On Race, Thanks To The FDA


It’s not just New York prioritizing non-white residents for COVID-19 treatments, Utah and Minnesota are also doing it.

As The Washington Free Beacon reported, the scheme didn’t start at state-level health departments, it began with the Food and Drug Administration (FDA).

“In New York, racial minorities are automatically eligible for scarce COVID-19 therapeutics, regardless of age or underlying conditions. In Utah, ‘Latinx ethnicity’ counts for more points than ‘congestive heart failure’ in a patient’s ‘COVID-19 risk score’—the state’s framework for allocating monoclonal antibodies. And in Minnesota, health officials have devised their own ‘ethical framework’ that prioritizes black 18-year-olds over white 64-year-olds—even though the latter are at much higher risk of severe disease,” the Free Beacon reported.

Trending: Trump Reacts To Biden’s First Year In Office In Phone Interview With Sean Hannity (VIDEO)

The racial discrimination stems from the FDA’s guidance when authorizing monoclonal antibodies

Continue reading

You Might Like

 

Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!

Thanks for sharing!
Send this to a friend